Author

M. J. Nicklin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

D. C. James· 2 shared A. Brown· 1 shared A. O. Johnson· 1 shared J. Grinham· 1 shared J. M. Scarrott· 1 shared J. Price· 1 shared K. L. Tee· 1 shared L. J. Partridge· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

D. C. James

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ACE2-independent interaction of SARS-CoV-2 spike protein to human epithelial cells can be inhibited by unfractionated heparin

L. J. Partridge, L. Urwin, M. J. Nicklin, D. C. James, L. R. Green, P. N. Monk

This paper shows that SARS-CoV-2 spike protein can interact with human cells without ACE2 and that unfractionated heparin inhibits this interaction.

Cells · Jun 7, 2021Peer-reviewedMicrobiology

Purification of recombinant SARS-CoV-2 spike, its receptor binding domain, and CR3022 mAb for serological assay

K. L. Tee, P. J. Jackson, J. M. Scarrott, S. R. Jaffe, A. O. Johnson, Y. Johari, T. H. Pohle, T. Mozzanino, J. Price, J. Grinham, A. Brown, M. J. Nicklin, D. C. James, M. J. Dickman, T. S. Wong

The paper describes methods for purifying SARS-CoV-2 spike protein, its receptor binding domain, and CR3022 mAb, and validates their use in serological assays.

bioRxiv · Jul 31, 2020 · PreprintBiochemistry